105 related articles for article (PubMed ID: 12501502)
41. [Study on the progress of the mechanism of TGF-beta in the scarring and the effect of TCM].
Wang RG; Zhou W; Zhang YD
Zhongguo Gu Shang; 2008 Feb; 21(2):161-3. PubMed ID: 19105500
[TBL] [Abstract][Full Text] [Related]
42. Fibrosis linked to TGF-beta in yet another disease.
Border WA; Noble NA
J Clin Invest; 1995 Aug; 96(2):655-6. PubMed ID: 7635957
[No Abstract] [Full Text] [Related]
43. TGF-beta in renal allograft rejection.
Cohen AH; Nast CC
Miner Electrolyte Metab; 1998; 24(2-3):197-201. PubMed ID: 9525705
[TBL] [Abstract][Full Text] [Related]
44. TGF-beta in kidney fibrosis: a target for gene therapy.
Border WA; Noble NA
Kidney Int; 1997 May; 51(5):1388-96. PubMed ID: 9150449
[No Abstract] [Full Text] [Related]
45. Transforming growth factor beta in tissue fibrosis.
Border WA; Noble NA
N Engl J Med; 1994 Nov; 331(19):1286-92. PubMed ID: 7935686
[No Abstract] [Full Text] [Related]
46. TGF-beta and fibrosis.
Branton MH; Kopp JB
Microbes Infect; 1999 Dec; 1(15):1349-65. PubMed ID: 10611762
[TBL] [Abstract][Full Text] [Related]
47. [Transforming growth factor (TGF)].
Machide M; Nakamura T
Nihon Rinsho; 2005 Aug; 63 Suppl 8():93-8. PubMed ID: 16149461
[No Abstract] [Full Text] [Related]
48. The emerging role of transforming growth factor-beta in kidney diseases.
Sharma K; Ziyadeh FN
Am J Physiol; 1994 Jun; 266(6 Pt 2):F829-42. PubMed ID: 8023963
[TBL] [Abstract][Full Text] [Related]
49. Transforming growth factor-beta and matrix protein expression in acute and chronic rejection of human renal allografts.
Shihab FS; Yamamoto T; Nast CC; Cohen AH; Noble NA; Gold LI; Border WA
J Am Soc Nephrol; 1995 Aug; 6(2):286-94. PubMed ID: 7579098
[TBL] [Abstract][Full Text] [Related]
50. Basic science for the clinician 57: transforming growth factor β.
Sigal LH
J Clin Rheumatol; 2012 Aug; 18(5):268-72. PubMed ID: 22832292
[TBL] [Abstract][Full Text] [Related]
51. Potential involvement of growth factors in the proliferation of arteriolar smooth muscle cells during chronic graft rejection.
Vuillemin T; Lantz O; Legendre C; Meduri G; LaRue JR; Kriaa F; Hiesse C; Senik A; Kreis H; Charpentier B
Adv Nephrol Necker Hosp; 1996; 25():39-49. PubMed ID: 8717619
[No Abstract] [Full Text] [Related]
52. The role of transforming growth factor-beta in transplant rejection.
Hutchinson IV
Transplant Proc; 1999 Nov; 31(7A):9S-13S. PubMed ID: 10576034
[No Abstract] [Full Text] [Related]
53. The role of transforming growth factor beta in chronic renal allograft nephropathy.
Jain S; Furness PN; Nicholson ML
Transplantation; 2000 May; 69(9):1759-66. PubMed ID: 10830203
[No Abstract] [Full Text] [Related]
54. Peaks of transforming growth factor-beta mRNA in alveolar cells of lung transplant recipients as an early marker of chronic rejection.
Charpin JM; Valcke J; Kettaneh L; Epardeau B; Stern M; Israël-Biet D
Transplantation; 1998 Mar; 65(5):752-5. PubMed ID: 9521216
[TBL] [Abstract][Full Text] [Related]
55. TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology.
Morikawa M; Derynck R; Miyazono K
Cold Spring Harb Perspect Biol; 2016 May; 8(5):. PubMed ID: 27141051
[TBL] [Abstract][Full Text] [Related]
56. A high concentration of TGF-β correlates with opportunistic infection in liver and kidney transplantation.
Boix F; Alfaro R; Jiménez-Coll V; Mrowiec A; Martínez-Banaclocha H; Botella C; Moya-Quiles MR; Sánchez-Bueno F; Robles R; de la Peña-Moral J; Ramirez P; Pons JA; Llorente S; Minguela A; Muro M
Hum Immunol; 2021 Jun; 82(6):414-421. PubMed ID: 33814194
[TBL] [Abstract][Full Text] [Related]
57. Therapeutic targets in the treatment of allograft fibrosis.
Mannon RB
Am J Transplant; 2006 May; 6(5 Pt 1):867-75. PubMed ID: 16611322
[TBL] [Abstract][Full Text] [Related]
58. Emerging strategies to disrupt the central TGF-β axis in kidney fibrosis.
Rauchman M; Griggs D
Transl Res; 2019 Jul; 209():90-104. PubMed ID: 31085163
[TBL] [Abstract][Full Text] [Related]
59. Editorial: Triple-agent TGF-β.
Hegner B; Schaub T; Dragun D
J Leukoc Biol; 2013 Apr; 93(4):459-62. PubMed ID: 23547175
[No Abstract] [Full Text] [Related]
60. Transforming growth factor beta and cardiovascular diseases: the other facet of the 'protective cytokine'.
Dabek J; Kułach A; Monastyrska-Cup B; Gasior Z
Pharmacol Rep; 2006; 58(6):799-805. PubMed ID: 17220537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
